Aimmune’s PALFORZIA™ Scores FDA Win, Becomes the First Ever Treatment For Peanut Allergy
By Rajaneesh K. Gopinath, Ph.D. First Treatment Ever for Peanut Allergy California based biopharma, Aimmune Therapeutics today announced the USFDA approval of PALFORZIA™ for the treatment of children between ages 4 and 17 who …
Read More